Ibrahim Halil Sahin, Assistant Professor at UPMC Hillman Cancer Center, retweeted a post by Cancers MDPI on X, adding the following:
“Excited to lead this effort with intention to offer an up-to-date insight on advances in the space of precision medicine and immunotherapy for patients with colorectal cancer. Several practice-changing data has emerged, and we hope to provide an update on the efficacy of these agents and related biomarkers.”
Original post by Cancers MDPI:
“New Special Issue ‘Perspectives on the Efficacy and Biomarkers of Immunotherapy and Targeted Therapy for Patients with Colorectal Cancer,’ guest-edited by Dr. Ibrahim Halil Sahin, is open for submissions!”